Background:Immunosuppressive agents are still inefficient in preventing biopsy-proven acute rejection (BPAR) after expanded criteria donor (ECD) kidney transpla
Background:The incidence of cancer,diabetes,and autoimmune diseases has been increasing.Furthermore,there are more and more patients with solid organ transplant